Gaois

Search direction

Search mode

Filter results

Collections

2 results in 2 documents

  1. #2463825

    Aigéad icisipeintéanóch (EPA): > 3,0 %

    Eicosapentaenoic acid (EPA): > 3,0 %

    Commission Implementing Regulation (EU) 2022/966 of 21 June 2022 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use, the specific labelling requirements and specifications of the novel food Calanus finmarchicus oil (Text with EEA relevance)

  2. #2118702

    Mar sin féin, sa tuairim eolaíoch ón Údarás in 2012 maidir le Tolerable Upper Intake Level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA) [Uasleibhéal iontógála is inghlactha an aigéid icisipeintéanóch (EPA), an aigéid docaisiheicséanóch (DHA) agus aigéid docaisipeintéanóch (DPA)], tháinig sé ar an gconclúid sé nach cúis imní sábháilteachta don phobal i gcoitinne é iontógáil fhorlíontach DHA amháin suas le 1 g in aghaidh an lae.

    However, the Authority in its 2012 scientific opinion on the ‘Tolerable Upper Intake Level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA)’ concluded that supplemental intakes of DHA alone up to about 1 g/day do not raise safety concerns for the general population.

    Commission Implementing Regulation (EU) 2021/1326 of 10 August 2021 authorising the placing on the market of Schizochytrium sp. (FCC-3204) oil as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)